276 related articles for article (PubMed ID: 17868047)
1. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
Mann G; Attarbaschi A; Burkhardt B; Niggli F; Klapper W; Ludwig WD; Schrappe M; Zimmermann M; Gadner H; Reiter A;
Br J Haematol; 2007 Nov; 139(3):443-9. PubMed ID: 17868047
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
3. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
[TBL] [Abstract][Full Text] [Related]
4. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
5. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
8. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G
Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550
[TBL] [Abstract][Full Text] [Related]
9. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
Miles RR; Cairo MS; Satwani P; Zwick DL; Lones MA; Sposto R; Abromovitch M; Tripp S; Angiolillo AL; Roman E; Davenport V; Perkins SL
Br J Haematol; 2007 Aug; 138(4):506-12. PubMed ID: 17659054
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
Yeh KH; Cheng AL; Su IJ; Lin MT; Tien HF; Shen MC; Wang CH; Chen YC
Anticancer Res; 1997; 17(3C):2269-72. PubMed ID: 9216700
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols.
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Pediatr Blood Cancer; 2008 Mar; 50(3):633-5. PubMed ID: 17366531
[TBL] [Abstract][Full Text] [Related]
16. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
17. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
Hoelzer D; Gökbuget N
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
[TBL] [Abstract][Full Text] [Related]
18. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Burkhardt B; Woessmann W; Zimmermann M; Kontny U; Vormoor J; Doerffel W; Mann G; Henze G; Niggli F; Ludwig WD; Janssen D; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2006 Jan; 24(3):491-9. PubMed ID: 16421426
[TBL] [Abstract][Full Text] [Related]
19. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E; Oschlies I; Zimmermann M; Moser O; Graf N; Suttorp M; Greiner J; Reiter A;
Br J Haematol; 2008 Nov; 143(3):387-94. PubMed ID: 18729852
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
